Document is current
Any future updates will be listed below
-
Authors
Faurholt-Jepsen, Maria
Risom, Asbjørn
Dyreholt, Malene Schwarz
Kyster, Natacha Blauenfeldt
Christensen, Ellen Margrethe
Smidt, Birte
Knorr, Ulla
Brøndmark, Kim
Mathiesen, Anja
Cululejevic, Denis
Sjaelland, Rene
Nørbak-Emig, Henrik
Sponsor, Lotte Linnemann
Mardosas, Darius
Bukh, Jens Drachmann
Heller, Trine Vøgg
Iversen, Nanna
Vinberg, Maj
Budtz-Jørgensen, Esben
Kessing, Lars Vedel
-
Funding
Funding for this research was provided by:
Region Hovedstadens Psykiatri
Danmarks Frie Forskningsfond
- License Information
-
More Information
Article History
Received: 28 November 2025
Accepted: 5 March 2026
First Online: 22 March 2026
Declarations
:
: MFJ has within the last three years been a consultant for Janssen-Cilag. LVK has within the last three years been a consultant for Lundbeck and Teva. NI works at Monsenso A/S. MV have within the last there years received consultancy fee from Janssen-Cilag, Eli Lilly and Lundbeck. All other authors have no conflicts of interest to declare.
: Human ethics and consent to participate .
: Ethical permission was obtained from the Regional Ethics Committee in The Capital Region of Denmark and the data agency, Capital Region of Copenhagen (H-19067248, (P-2019-809)). All patients were provided with written and oral information and gave informed consent, in according to the Helsinki declaration. Any desire to leave the trial was accepted.
